Where is FALCONBIO located?

FALCONBIO is headquartered in Singapore, Singapore.

Which legal entities is FALCONBIO associated with?

FALCONBIO is associated with FALCONBIO Pte. Ltd.

Is FALCONBIO a funded company?

FALCONBIO is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does FALCONBIO rank among its competitors?

FALCONBIO ranks 19th amongst 23 active competitors, of which 8 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Parabilis Medicines, which secured $305M in Jan, 2026.

Who are the top competitors of FALCONBIO?

FALCONBIO's top competitors include Check-Cap, Parabilis Medicines and Sunbird Bio. Among them, Parabilis Medicines secured the most recent funding round in January, 2026.

FALCONBIO - 2026 Company Profile, Team, Funding & Competitors

FALCONBIO is a funded company based in Singapore (Singapore), founded in 2019 by Akshay Vishnu Bhat. It operates as a Developerof drug delivery system to treat cancer. The company has 23 active competitors, including 8 funded and 3 that have exited. Its top competitors include companies like Check-Cap, Parabilis Medicines and Sunbird Bio.

Company Details

Developerof drug delivery system to treat cancer. It offers ingestible cancer therapeutic solutions with the proprietary Smart Bacteria that destroy cancer cells of colorectal cancer.

Key Metrics

Founded Year

2019

Location

Singapore, Singapore

Stage

Funding Raised

Investors

Entrepreneur First

Ranked

19^th among 23 active competitors

Similar Companies

Check-Cap & 25 more

View FALCONBIO's full profile

FALCONBIO is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
FALCONBIO Pte. Ltd CIN: 201915828E , Singapore, Active		-	-

FALCONBIO is a funded company. FALCONBIO has 1 institutional investor.

View details of FALCONBIO's funding rounds and investors

The founders of FALCONBIO is Akshay Vishnu Bhat.

Here are the details of FALCONBIO's key team members:

Akshay Vishnu Bhat: Former Co-Founder of FALCONBIO. They serve on the board of 1 company.

FALCONBIO's Board of Directors

FALCONBIO's board has 1 active member. Stylianos Makrogkikas is part of team.

Here is the list of FALCONBIO's board of directors:

Name	Type	Representing	Status	Duration
Stylianos Makrogkikas	Team	-	Current	7y 1m
rtrseao	Team	-	Past	4y 8m

View details of FALCONBIO's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of FALCONBIO include Check-Cap, Parabilis Medicines and Sunbird Bio. Here is the list of Top 10 competitors of FALCONBIO, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Check-Cap 2005, Haifa (Israel), Public	Developer of imaging capsules for colorectal cancer screening	$9.88M	Pontifax, Docor & 11 others	63/100
2nd	Parabilis Medicines 2016, Cambridge (United States), Public	Developer of peptide therapeutics for the treatment of severe diseases	$628M	Fidelity Investments, PagsGroup & 26 others	61/100
3rd	Sunbird Bio 2020, Singapore, Series B	Developer of blood-based diagnostic tests for neurological disorders	$14M	EDBI, Lilly & 8 others	59/100
4th	Akamis Bio 2010, Cambridge (United States), Series D	Developer of therapeutics for the treatment of colorectal cancer	$179M	Imperial Innovations, Mercia & 30 others	56/100
5th	Isofol Medical 2008, Gothenburg (Sweden), Public	Developer of small molecules for colorectal cancer	-	Sahlgrenska Science Park	42/100
6th	New Element Medicine 2012, Zhenjiang (China), Series D	Developer of drugs for various cancer	$152M	Kaitai Capital Management, ShenZhen GTJA Investment Group ... & 11 others	41/100
7th	Lutris Pharma 2016, Tel Aviv (Israel), Series B	Provider of anti-cancer therapy	$30M	Pontifax, Columbus Venture Partners & 3 others	38/100
8th	ResistanceBio 2016, Menlo Park (United States), Series A	Developer of therapeutics for treatment-resistant cancer	$12.9M	NFX, Y Combinator & 17 others	35/100
9th	Jiangsu Sinorda Biomedicine 2010, Suzhou (China), Deadpooled	Developing personalised anticancer vaccines & diagnostics	-	Guiyang Venture Capital, Button Capital	34/100
10th	Origo Biopharma 2017, Ourense (Spain), Acqui-Hired	Manufacturer of immunotherapeutic products for research purpose	$2.6M	Asabys Partners, Xesgalicia	31/100
19th	FALCONBIO 2019, Singapore (Singapore), Funding Raised	Developerof drug delivery system to treat cancer	-	Entrepreneur First	20/100